Literature DB >> 6155408

Thymic hormonal activity on human peripheral blood lymphocytes in vitro. II. Enhancement of the production of immune interferon by activated cells.

J Shoham, I Eshel, M Aboud, S Salzberg.   

Abstract

The thymic extract TP-1 significantly enhanced the production of immune interferon (IF) by human peripheral blood mononuclear cells in Con A- or Raji- but not PHA-induced cultures. TP-1 effect was more pronounced under conditions of low IF production. The effect was evident before cell proliferation took place and without necessary concurrent effect of TP-1 on the blastogenic response. TP-1 had no detectable effect on nonactivated cultures. The enhancement of IF production by TP-1 to the degree demonstrated here necessitates consideration of its possible effects in every assay of thymic hormones that involves lectin or allogeneic stimulation of lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155408

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Modulation of NK activity by thymic hormones: in vitro effects of thymostimulin.

Authors:  A M Liberati; S Cinieri; M Fizzotti; M Schippa; S Ascani; V De Angelis; M Senatore; L Palmisano
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

2.  Feedback inhibition of thymic secretory activity in mice treated by the thymic extract TP-1 (thymostimulin).

Authors:  J Shoham; E Ben-David; U Sandbank
Journal:  Immunology       Date:  1982-01       Impact factor: 7.397

3.  Immunomodulatory effects of alpha interferon and thymostimulin in patients with neoplasias.

Authors:  I Munno; M Marinaro; A Gesario; B Cannuscio; Y Michel; E Paulling
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

4.  Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.

Authors:  M Fiorilli; M C Sirianni; F Pandolfi; I Quinti; U Tosti; F Aiuti; G Goldstein
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

5.  A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remission.

Authors:  A M Liberati; E Ballatori; M Fizzotti; M Schippa; L Cini; S Cinieri; M G Proietti; R Di Marzio; M Senatore; F Grignani
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.